sulforaphane/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases triglycerides
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Sulforaphane led to significant reductions in metabolic markers, including LDL, triglycerides, and cholesterol.”
Quoted verbatim from Efficacy and safety of sulforaphane in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Patients with schizophrenia in pooled randomized controlled trials of sulforaphane versus control
Efficacy and safety of sulforaphane in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.2025PMID:41184790Permalink
Keep reading
- Everything the graph holds on sulforaphane
- Every compound studied against Triglycerides
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PJW3394PJN0CY46B5VXP6N